• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗真菌药物的使用影响重症监护病房中念珠菌属种的分布和药敏性。

Antifungal use influences Candida species distribution and susceptibility in the intensive care unit.

机构信息

Parasitology-Mycology Laboratory, Infectious Agent Department, Albert Michallon University Hospital and Joseph Fourier University, Grenoble, France.

出版信息

J Antimicrob Chemother. 2011 Dec;66(12):2880-6. doi: 10.1093/jac/dkr394. Epub 2011 Oct 6.

DOI:10.1093/jac/dkr394
PMID:21980066
Abstract

OBJECTIVES

Antifungal prescription practices have changed over the last decade, and the impact of these changes is unclear. Our objective here was to evaluate the effect of antifungal drug use on the distribution and drug susceptibility of Candida spp. in a French intensive care unit (ICU).

METHODS

Antifungal drug use was measured as the number of defined daily doses per 1000 hospital days (DDDs/1000HD). The distribution of Candida spp. over a 6 year period (2004-09) and the MICs of antifungal drugs over 2007-09 were determined. Statistical analyses were performed to assess relationships between antifungal drug use, Candida spp. distribution and MIC changes over time.

RESULTS

Of 26,450 samples from 3391 patients, 1511 were positive for Candida spp. Candida albicans predominated (52.5%), followed by Candida glabrata (16.6%) and Candida parapsilosis (7.5%). C. parapsilosis increased significantly, from 5.7% in 2004 to 12.5% in 2009 (P = 0.0005). Caspofungin use increased significantly between 2004 (17.9 DDDs/1000HD) and 2009 (69.9 DDDs/1000HD) (P < 0.0001). Between 2007 and 2009, the increase in caspofungin use correlated significantly with the increase in caspofungin MICs displayed by C. parapsilosis (P < 0.0001) and C. glabrata (P = 0.03). Amphotericin B consumption changed over time and correlated with an increase in amphotericin B MICs for C. albicans (P = 0.0002) and C. glabrata (P = 0.0005). Significant declines occurred in both fluconazole use (P < 0.0001) and fluconazole MICs of C. albicans (P < 0.001)

CONCLUSIONS

Antifungal drug use in the ICU is associated with major changes in the distribution and drug susceptibility of Candida spp.

摘要

目的

过去十年中,抗真菌药物的使用情况发生了变化,但其影响尚不清楚。本研究旨在评估法国重症监护病房(ICU)中抗真菌药物使用对念珠菌属分布和药敏性的影响。

方法

采用每 1000 个住院日的限定日剂量数(DDD/1000HD)来衡量抗真菌药物的使用情况。在 2004 年至 2009 年的 6 年期间,确定了念珠菌属的分布情况和 2007 年至 2009 年抗真菌药物的 MIC 值。采用统计学分析评估抗真菌药物使用、念珠菌属分布和 MIC 随时间变化之间的关系。

结果

在 3391 例患者的 26450 份样本中,有 1511 份样本为念珠菌属阳性。最常见的是白色念珠菌(52.5%),其次是光滑念珠菌(16.6%)和近平滑念珠菌(7.5%)。近平滑念珠菌的比例显著增加,从 2004 年的 5.7%增加到 2009 年的 12.5%(P=0.0005)。2004 年(17.9 DDDs/1000HD)至 2009 年(69.9 DDDs/1000HD)期间,卡泊芬净的使用显著增加(P<0.0001)。2007 年至 2009 年期间,卡泊芬净使用量的增加与近平滑念珠菌(P<0.0001)和光滑念珠菌(P=0.03)对卡泊芬净 MIC 值的增加显著相关。两性霉素 B 的消耗量随时间而变化,并与白色念珠菌(P=0.0002)和光滑念珠菌(P=0.0005)对两性霉素 B MIC 值的增加相关。氟康唑的使用量(P<0.0001)和白色念珠菌的氟康唑 MIC 值(P<0.001)均显著下降。

结论

ICU 中抗真菌药物的使用与念珠菌属的分布和药敏性发生重大变化有关。

相似文献

1
Antifungal use influences Candida species distribution and susceptibility in the intensive care unit.抗真菌药物的使用影响重症监护病房中念珠菌属种的分布和药敏性。
J Antimicrob Chemother. 2011 Dec;66(12):2880-6. doi: 10.1093/jac/dkr394. Epub 2011 Oct 6.
2
Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years.抗真菌药物处方对念珠菌属相对分布和药敏性的影响-10 年趋势。
J Infect. 2016 Jan;72(1):103-11. doi: 10.1016/j.jinf.2015.09.041. Epub 2015 Oct 28.
3
Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey.不同医院病房念珠菌属的流行情况及其对抗真菌药物的敏感性:一项为期三年的调查结果
J Prev Med Hyg. 2008 Jun;49(2):69-74.
4
[Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].五年期间(1997 - 2001年)血培养中念珠菌属分离株的抗真菌药敏情况
Enferm Infecc Microbiol Clin. 2003 Nov;21(9):488-92.
5
Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.对重症监护病房患者分离出的念珠菌属进行鉴定以及为期3年的氟康唑体外药敏试验。
Mycoses. 2007 Jan;50(1):52-7. doi: 10.1111/j.1439-0507.2006.01309.x.
6
[Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].[从重症监护病房患者尿液样本中分离出的念珠菌属的分子流行病学及抗真菌药敏性]
Mikrobiyol Bul. 2011 Jan;45(1):137-49.
7
[Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].[用于对从血培养中分离出的念珠菌属菌株进行抗真菌药敏试验的肉汤微量稀释法与E-test法的比较]
Mikrobiyol Bul. 2010 Apr;44(2):263-71.
8
Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.土耳其一家医疗中心新生儿及儿科重症监护病房患者念珠菌分离株的物种分布、抗真菌药敏性及克隆相关性
New Microbiol. 2008 Jul;31(3):401-8.
9
Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.重症监护病房念珠菌血症的发生率及其与氟康唑使用的关系。
J Antimicrob Chemother. 2009 Sep;64(3):625-9. doi: 10.1093/jac/dkp251. Epub 2009 Jul 21.
10
Effect of fluconazole consumption on long-term trends in candidal ecology.氟康唑摄入对念珠菌生态长期趋势的影响。
J Antimicrob Chemother. 2006 Aug;58(2):474-7. doi: 10.1093/jac/dkl241. Epub 2006 Jun 6.

引用本文的文献

1
Increasing antifungal resistance in Eastern India (2019-2023): A notable rise in amphotericin B resistance.印度东部地区抗真菌耐药性增加(2019 - 2023年):两性霉素B耐药性显著上升。
Curr Med Mycol. 2024 Nov 15;10. doi: 10.22034/cmm.2024.345262.1555. eCollection 2024.
2
Invasive Candidiasis in the Intensive Care Unit: Where Are We Now?重症监护病房中的侵袭性念珠菌病:我们目前的状况如何?
J Fungi (Basel). 2025 Mar 27;11(4):258. doi: 10.3390/jof11040258.
3
: Multidrug Resistance and Increased Virulence in a Major Opportunistic Fungal Pathogen.
一种主要机会性真菌病原体中的多药耐药性与毒力增强
Curr Fungal Infect Rep. 2012 Jun;6(3):154-164. doi: 10.1007/s12281-012-0091-0.
4
Understanding the clinical and environmental drivers of antifungal resistance in the One Health context.在“同一健康”背景下理解抗真菌药物耐药性的临床和环境驱动因素。
Microbiology (Reading). 2024 Oct;170(10). doi: 10.1099/mic.0.001512.
5
Complex: The Current State of Infections and Drug Resistance in Humans.综合报告:人类感染与耐药性的现状
J Fungi (Basel). 2024 Apr 18;10(4):294. doi: 10.3390/jof10040294.
6
Retrospective Evaluation of Risk Factors for Invasive Infections in a Medical Intensive Care Unit.医学重症监护病房侵袭性感染危险因素的回顾性评估
Infect Dis Clin Microbiol. 2022 Feb 14;4(1):62-71. doi: 10.36519/idcm.2022.56. eCollection 2022 Mar.
7
An Analysis of the Use of Systemic Antifungals (Fluconazole, Itraconazole, and Terbinafine) in Galicia, Spain, between 2019 and 2022.2019年至2022年西班牙加利西亚地区全身性抗真菌药物(氟康唑、伊曲康唑和特比萘芬)使用情况分析
Diseases. 2024 Jan 12;12(1):22. doi: 10.3390/diseases12010022.
8
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis.抗真菌治疗优化在治疗腹腔内念珠菌病中的药代动力学和药效学考虑因素。
Crit Care. 2023 Nov 20;27(1):449. doi: 10.1186/s13054-023-04742-w.
9
Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center.在一家学术医疗中心针对米卡芬净开展的抗真菌管理倡议评估
Antibiotics (Basel). 2023 Jan 17;12(2):193. doi: 10.3390/antibiotics12020193.
10
Surveillance of Antifungal Resistance in Candidemia Fails to Inform Antifungal Stewardship in European Countries.念珠菌血症中抗真菌药物耐药性监测未能为欧洲国家的抗真菌药物管理提供信息。
J Fungi (Basel). 2022 Feb 28;8(3):249. doi: 10.3390/jof8030249.